CENCORA, INC. for CENCORA, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Advancing Emergency Preparedness through One Health Act. Strengthening Americas Strategic National Stockpile Act. Essential Medicines Strategic Stockpile Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| VIVIENNE STAFFORD MITCHELL | — |
| RITA E NORTON | — |
| ASHLEY ROSE O'SULLIVAN | — |
Pharmacy PHA
Legislation to provide for coverage under Medicare program of pharmacist services. Pharmacy and Medically Underserved Area Enhancement Act. Medication therapy management. Legislation to prohibit prescription drug plan sponsors and MAPD organizations under Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. House and Senate Agriculture, FDA, and related agency Appropriations bills. Prescription drug importation. Phair Pricing Act. Pharmacy DIR Reform To Reduce Senior Drug Costs Act. Issues and policies related to generic drug shortages. Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program and Health Care Enhancement Act. Federal Retail Pharmacy Partnership for COVID-19 vaccine. American Rescue Plan. Permanent Extension of PREP Act Declarations. The Ensuring Seniors Access to Local Pharmacies Act. S.1388 - Prescription Pricing for the People Act of 2021. Long-Term Care Pharmacy Definition Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| VIVIENNE STAFFORD MITCHELL | — |
| RITA E NORTON | — |
| ASHLEY ROSE O'SULLIVAN | — |
Medicare/Medicaid MMM
Medicare Prompt Pay Discount Exclusion - legislation to ensure more appropriate general payment amount for drugs and biologics under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price (ASP). ASP generally (in the context of deficit reduction). Removal of Safe Harbor protection for rebates to plans of PBMs involving prescription pharmaceuticals and creation of new Safe Harbor protection. International Pricing Index Model. Competitive Acquisition Program. Medicare Part B Biosimilar Reimbursement. Proposed modifications to the existing definition of distributor bona fide service fees in Medicare Part B. Recognizing pharmacists as providers within Medicare for COVID-19 response. Paycheck Protection Program and Health Care Enhancement Act. Most Favored Nation (MFN) policy. Medicare Sequester Relief Act (H.R. 1868). American Rescue Plan. The Bolstering Innovative Options to Save Immediately on Medicines (BIOSIM) Act (H.R. 2815). Build Back Better Act. Protecting Medicare and American Farmers from Sequester Cuts Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| VIVIENNE STAFFORD MITCHELL | — |
| RITA E NORTON | — |
| ASHLEY ROSE O'SULLIVAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.